Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:07 PM
Ignite Modification Date:
2025-12-24 @ 5:07 PM
NCT ID:
NCT04767750
Eligibility Criteria:
• HCC cases (group I):
Inclusion criteria:
\- Patients aged 40 years or older with a confirmed diagnosis of HCC through triphasic CT and/or dynamic MRI (European Association for the Study of the Liver, 2012).
Exclusion criteria:
* Patients who underwent previous cancer-directed treatment (radiation and/or chemotherapy).
* Patients with any other systemic disease (Renal disease, other primary tumors).
* T2DM cases (group II):
Inclusion criteria:
\- Clinically diagnosed T2DM patients aged 40 years or older frequenting Mansoura Specialized Medical Hospital.
Exclusion criteria:
* Patients with previous or current malignancies.
* Patients with diabetic complications (Diabetic retinopathy, neuropathy, nephropathy).
* Patients with other systemic diseases.
* HCC \& T2DM cases (group III):
Inclusion criteria:
\- Patients aged 40 years or older with a confirmed diagnosis of HCC through triphasic CT and/or dynamic MRI and who are clinically diagnosed to have T2DM.
Exclusion criteria:
* Patients who underwent previous cancer-directed treatment (radiation and/or chemotherapy).
* Patients with any other systemic disease.
• Controls (group IV):
* Apparently healthy, age, and gender-matched subjects.
* No history of malignant disease, diabetes, or HCV.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT04767750
Study Brief:
Protocol Section:
NCT04767750